Related references
Note: Only part of the references are listed.Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens
Tania Mareike Viertel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Application of the VPp1 bacteriophage combined with a coupled enzyme system in the rapid detection of Vibrio parahaemolyticus
Yong Peng et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2014)
Phenotypic Resistance and the Dynamics of Bacterial Escape from Phage Control
James J. Bull et al.
PLOS ONE (2014)
A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis
Jessica Tsonos et al.
VETERINARY MICROBIOLOGY (2014)
Hurdles in bacteriophage therapy: Deconstructing the parameters
Jessica Tsonos et al.
VETERINARY MICROBIOLOGY (2014)
Challenges in predicting the evolutionary maintenance of a phage transgene
Matthew Schmerer et al.
JOURNAL OF BIOLOGICAL ENGINEERING (2014)
Predicting In Vivo Efficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections
Marine Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Phage cocktails and the future of phage therapy
Benjamin K. Chan et al.
FUTURE MICROBIOLOGY (2013)
Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections
Sanjay Chhibber et al.
PLOS ONE (2013)
Bacteriophage adhering to mucus provide a non-host-derived immunity
Jeremy J. Barr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Light-tagged bacteriophage as a diagnostic tool for the detection of phytopathogens (vol 78, pg 3592, 2012)
David A. Schofield et al.
BIOENGINEERED (2013)
In Vivo Growth Rates Are Poorly Correlated with Phage Therapy Success in a Mouse Infection Model
J. J. Bull et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Spatial Vulnerability: Bacterial Arrangements, Microcolonies, and Biofilms as Responses to Low Rather than High Phage Densities
Stephen T. Abedon
VIRUSES-BASEL (2012)
Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage
Eric G. Gladstone et al.
JOURNAL OF BIOLOGICAL ENGINEERING (2012)
Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin
Marzia Rahman et al.
BIOFOULING (2011)
Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection
Vivek Daniel Paul et al.
BMC MICROBIOLOGY (2011)
Non invasive real-time monitoring of bacterial infection & therapeutic effect of anti-microbials in five mouse models
TaraniKanta Barman et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2011)
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy
Elizabeth M. Ryan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae
Vivek Verma et al.
BIOFOULING (2010)
Phage Therapy for Plant Disease Control
B. Balogh et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Designing Phage Therapeutics
Lawrence D. Goodridge
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Phage Therapy Pharmacology
Stephen T. Abedon et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Phage Choice, Isolation, and Preparation for Phage Therapy
Jason J. Gill et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Bacteriophage Therapy of Salmonella enterica: A Fresh Appraisal of Bacteriophage Therapy
Rosanna Capparelli et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Bacteriophage-Resistant Staphylococcus aureus Mutant Confers Broad Immunity against Staphylococcal Infection in Mice
Rosanna Capparelli et al.
PLOS ONE (2010)
A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli
J. J. Bull et al.
VIROLOGY (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment
Vivek Verma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Timothy K. Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055
Manmeet Sakshi Bedi et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2009)
Using Bacteriophages to Modulate Salmonella Colonization of the Chicken's Gastrointestinal Tract: Lessons Learned from In Silico and In Vivo Modeling
A. Hurley et al.
AVIAN DISEASES (2008)
The use of phages for the removal of infectious biofilms
J. Azeredo et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Bacteriophage influence Campylobacter jejuni types populating broiler chickens
Andrew E. Scott et al.
ENVIRONMENTAL MICROBIOLOGY (2007)
Dispersing biofilms with engineered enzymatic bacteriophage
Timothy K. Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bacteriophage therapy to reduce Salmonella colonization of broiler chickens
R. J. Atterbury et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Pharmacodynarnics of non-replicating viruses, bacteriocins and lysins
James J. Bull et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K
J. J. Gill et al.
JOURNAL OF APPLIED MICROBIOLOGY (2006)
Evolutionary feedback mediated through population density, illustrated with viruses in chemostats
JJ Bull et al.
AMERICAN NATURALIST (2006)
Escherichia coli K1's capsule is a barrier to bacteriophage T7
D Scholl et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model
T Matsuda et al.
SURGERY (2005)
Expression of viral EPS-depolymerase reduces fire blight susceptibility in transgenic pear
M Malnoy et al.
PLANT CELL REPORTS (2005)
Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk
S O'Flaherty et al.
LETTERS IN APPLIED MICROBIOLOGY (2005)
Models of phage growth and their applicability to phage therapy
RJ Weld et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Population and evolutionary dynamics of phage therapy
BR Levin et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage
S Hagens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Therapeutic efficacy of bacteriophage and baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers
WE Huff et al.
POULTRY SCIENCE (2004)
Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype
N Mushtaq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections
C Westwater et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage φMR11
S Matsuzaki et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Pharmacokinetic principles of bacteriophage therapy
RJH Payne et al.
CLINICAL PHARMACOKINETICS (2003)
Understanding bacteriophage therapy as a density-dependent kinetic process
RJH Payne et al.
JOURNAL OF THEORETICAL BIOLOGY (2001)
Share Paper
